Ibuprofen API Market to grow at a CAGR of 2.53% from 2022 to 2027, Driven by the increasing geriatric population - Technavio

NEW YORK, March 20, 2023 /PRNewswire/ -- The global ibuprofen API market size is estimated to grow by USD 31.68 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 2.53% during the forecast period. The growing geriatric population is driving the market growth significantly, although factors such as stringent regulations on ibuprofen API may impede the market growth. 

For more insights on the historic market data (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - buy the report!

Ibuprofen API Market - Segmentation Assessment

Segment Overview

Technavio has segmented the market based on end-user (pharmaceutical companies and contract manufacturing organizations), product (prescription and over-the-counter), and geography (Asia, North America, Europe, and Rest of World (ROW).

• The market share growth by the pharmaceutical companies segment will be significant for the market growth during the forecast period. Due to its wide range of applications, such as easing mild to moderate pain, including toothache, migraine, and menstrual cramps, Ibuprofen API is one of the most popular products in this segment. It is used as an analgesic and antipyretic agent. Ibuprofen API has anti-inflammatory properties and is used in the treatment of various conditions, such as rheumatoid arthritis and osteoarthritis.

Geography Overview

By geography, the global ibuprofen API market is segmented into Asia, North America, Europe, and the Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global ibuprofen API market.

• Asia is estimated to contribute to 42% of the growth of the global market during the forecast period. The growth can be attributed to factors such as the growing prevalence of migraine, chronic disorders, and other disorders. The manufacturing of pharmaceutical drugs is increasing in Asia due to low manufacturing costs in China and India. Resultantly, the number of production facilities has increased. The increasing geriatric population, who are more prone to chronic diseases will also drive the growth of the ibuprofen API market in Asia. Thus, the anticipated rise in population is expected to fuel the demand for innovative pain relief, driving the growth of the market during the forecast period.

Insights on the market contribution of various segments including country and region wise, historic (2017 to 2021) and forecast market size (2023 to 2027) - Download a Sample Report

Ibuprofen API Market – Vendor Analysis

The global ibuprofen API market is fragmented, with some of the global vendors holding the major share. Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt Ltd., Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Titan Lab Pvt Ltd., and Otto Brandes GmbH are some of the major vendors in the market.

Ibuprofen API Market – Market Dynamics

Key factor driving market growth

The rising geriatric population is significantly driving the ibuprofen active pharmaceutical ingredient (API) market growth. The risk of contracting chronic illness increases with age fueling the demand for ibuprofen APIs. The number of US adults aged 65 years and above is expected to reach approximately 71 million, which will increase the diagnosis of age-related diseases in the susceptible patient population, which will fuel the adoption of different therapeutics. National healthcare regulatory bodies promote the use of generic drugs to reduce the impact of economic burden. 

Leading trends influencing the market 

The paradigm shift in API manufacturing is a major trend influencing the ibuprofen active pharmaceutical ingredient (API) market growth. Various pharmaceutical companies outsource a large share of their research and manufacturing processes to drug manufacturing organizations. Outsourcing manufacturing is helpful for small organizations that do not have the internal capacity and financial budget to manufacture ibuprofen APIs in-house because it saves time invested in manufacturing. Hence, the paradigm shift from captive ibuprofen API manufacturing to contract ibuprofen API manufacturing is expected to have a positive impact on market growth during the forecast period.

Major challenges hindering the market growth

Stringent regulations on ibuprofen API are challenges impeding the ibuprofen active pharmaceutical ingredient (API) market growth. Regulatory authorities need to evaluate drug-related data carefully before approval by examining aspects such as safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions. A drug applicant needs to furnish additional data about the drug after receiving a CRL, which may require additional clinical trials and increase the R&D expenditure of the drug. If failed, the applicant may receive a complete response letter (CRL) or face complete rejection from regulatory agencies. Thus, such stringent regulations may impede the market growth during the forecast period.

Insights on market drivers, trends, & challenges, historic period(2017 to 2021) and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Ibuprofen API Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the Ibuprofen API market between 2023 and 2027
• Precise estimation of the size of the Ibuprofen API market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the Ibuprofen API market across Asia, North America, Europe, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of Ibuprofen API market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

Interstitial cystitis (IC) drugs market is estimated to grow at a CAGR of 5.9% between 2022 and 2027. The size of the market is forecast to increase by USD 369.58 million. The market is segmented by type (oral therapy and intravesical therapy), by Distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and by geography segment (North America, Europe, Asia, and the Rest of World (ROW)). The high prevalence of interstitial cystitis is notably driving the IC drugs market growth. 

The isobutyl benzene market size is expected to increase by USD 13.85 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 4.67%. The market is segmented by end-user (pharmaceuticals and others) and geography (APAC, Europe, North America, MEA, and South America). The high demand for ibuprofen is one of the major factors driving the growth of the global isobutyl benzene market. 

Browse through Technavio's Health Care Market Reports

Table of contents:

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global ibuprofen API market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global ibuprofen API market 2017 - 2021 ($ million)

• 4.2 End user Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – End user Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user

• 6.3 Pharmaceutical companies - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)

• 6.4 Contract manufacturing organizations - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by End-user 
• Exhibit 42: Market opportunity by End-user ($ million)
• Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 44: Chart on Product - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 46: Chart on Comparison by Product
• Exhibit 47: Data Table on Comparison by Product

• 7.3 Prescription - Market size and forecast 2022-2027 
• Exhibit 48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)

• 7.4 Over-the-counter - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Over-the-counter - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Over-the-counter - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Over-the-counter - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Over-the-counter - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Product 
• Exhibit 56: Market opportunity by Product ($ million)
• Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 59: Chart on Market share by geography 2022-2027 (%)
• Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison

• 9.3 Asia - Market size and forecast 2022-2027 
• Exhibit 63: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.4 North America - Market size and forecast 2022-2027 
• Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.5 Europe - Market size and forecast 2022-2027 
• Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 India - Market size and forecast 2022-2027 
• Exhibit 83: Chart on India - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on India - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on India - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027 
• Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 Germany - Market size and forecast 2022-2027 
• Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.11 UK - Market size and forecast 2022-2027 
• Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 99: Market opportunity by geography ($ million)
• Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 106: Matrix on vendor position and classification

• 12.3 Athos Chemicals Pvt. Ltd. 
• Exhibit 107: Athos Chemicals Pvt. Ltd. - Overview
• Exhibit 108: Athos Chemicals Pvt. Ltd. - Product / Service
• Exhibit 109: Athos Chemicals Pvt. Ltd. - Key offerings

• 12.4 Azelis SA
• Exhibit 110: Azelis SA - Overview
• Exhibit 111: Azelis SA - Product / Service
• Exhibit 112: Azelis SA - Key offerings

• 12.5 BASF SE
• Exhibit 113: BASF SE - Overview
• Exhibit 114: BASF SE - Business segments
• Exhibit 115: BASF SE - Key news
• Exhibit 116: BASF SE - Key offerings
• Exhibit 117: BASF SE - Segment focus

• 12.6 Chemino Pharma Ltd.
• Exhibit 118: Chemino Pharma Ltd. - Overview
• Exhibit 119: Chemino Pharma Ltd. - Product / Service
• Exhibit 120: Chemino Pharma Ltd. - Key offerings

• 12.7 Dr Reddys Laboratories Ltd. 
• Exhibit 121: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 122: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 123: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 124: Dr Reddys Laboratories Ltd. - Segment focus

• 12.8 Granules India Ltd.
• Exhibit 125: Granules India Ltd. - Overview
• Exhibit 126: Granules India Ltd. - Product / Service
• Exhibit 127: Granules India Ltd. - Key news
• Exhibit 128: Granules India Ltd. - Key offerings

• 12.9 IOL Chemicals and Pharmaceuticals Ltd. 
• Exhibit 129: IOL Chemicals and Pharmaceuticals Ltd. - Overview
• Exhibit 130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
• Exhibit 131: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
• Exhibit 132: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus

• 12.10 Octavius Pharma Pvt Ltd. 
• Exhibit 133: Octavius Pharma Pvt Ltd. - Overview
• Exhibit 134: Octavius Pharma Pvt Ltd. - Product / Service
• Exhibit 135: Octavius Pharma Pvt Ltd. - Key offerings

• 12.11 Piramal Enterprises Ltd. 
• Exhibit 136: Piramal Enterprises Ltd. - Overview
• Exhibit 137: Piramal Enterprises Ltd. - Business segments
• Exhibit 138: Piramal Enterprises Ltd. - Key offerings
• Exhibit 139: Piramal Enterprises Ltd. - Segment focus

• 12.12 Rochem International Inc. 
• Exhibit 140: Rochem International Inc. - Overview
• Exhibit 141: Rochem International Inc. - Product / Service
• Exhibit 142: Rochem International Inc. - Key offerings

• 12.13 SI Group Inc.
• Exhibit 143: SI Group Inc. - Overview
• Exhibit 144: SI Group Inc. - Product / Service
• Exhibit 145: SI Group Inc. - Key offerings

• 12.14 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. 
• Exhibit 146: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
• Exhibit 147: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 148: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings

• 12.15 Solara Active Pharma Sciences Ltd. 
• Exhibit 149: Solara Active Pharma Sciences Ltd. - Overview
• Exhibit 150: Solara Active Pharma Sciences Ltd. - Product / Service
• Exhibit 151: Solara Active Pharma Sciences Ltd. - Key offerings

• 12.16 Strides Pharma Science Ltd. 
• Exhibit 152: Strides Pharma Science Ltd. - Overview
• Exhibit 153: Strides Pharma Science Ltd. - Business segments
• Exhibit 154: Strides Pharma Science Ltd. - Key offerings
• Exhibit 155: Strides Pharma Science Ltd. - Segment focus

• 12.17 Teva Pharmaceutical Industries Ltd. 
• Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 161: Inclusions checklist
• Exhibit 162: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 163: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 164: Research methodology
• Exhibit 165: Validation techniques employed for market sizing
• Exhibit 166: Information sources

• 13.5 List of abbreviations 
• Exhibit 167: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio